Global Intracranial Aneurysm Market Report and Forecast 2025-2034

Global Intracranial Aneurysm Market Outlook

The global intracranial aneurysm market size was valued at USD 1.2 billion in 2024, driven by the rising cases of intracranial aneurysm along with the growing demand for minimally invasive procedures across the globe. The market is expected to grow at a CAGR of 8.8% during the forecast period of 2025-2034, with the values likely to rise from USD 1.3 billion in 2025 to USD 2.6 billion by 2034.

Key Takeaways

• Around 6.8 million individuals have an unruptured intracranial aneurysm in the United States, with nearly 30,000 people suffering a rupture annually.

• In May 2023, Stryker Corporation acquired Cerus Endovascular Ltd., a medical devices company specializing in neurointerventional devices to expand its neurovascular division.

• The common risk factors of intracranial aneurysms include high blood pressure, smoking, and being over 40 years of age.

Intracranial aneurysm, also known as brain aneurysm or cerebral aneurysm, is characterized by a bulge in a blood vessel in the brain. If the aneurysm leaks or ruptures, it results in bleeding in the brain called a hemorrhagic stroke. There are three types of aneurysms, saccular, fusiform, and mycotic aneurysm, out of which the saccular or berry aneurysm is the most common. To repair a ruptured aneurysm, surgery or endovascular treatment is usually required.

The intracranial aneurysm market demand is driven by the rising prevalence of the condition along with heightened patient awareness and availability of advanced treatment options. Technological innovations in diagnostic techniques are facilitating early detection of aneurysms, allowing timely intervention. Moreover, the growing demand for minimally invasive procedures and increased research and development efforts aimed at improving existing treatments and discovering novel therapeutics are anticipated to propel the market growth in the forecast period.

Global Intracranial Aneurysm Market Trends and Developments

Advancements in endovascular techniques, technological innovations, increased application of flow diverters, and growing preference for minimally invasive procedures comprise some of the key trends in the market.

Global Intracranial Aneurysm Market Growth Factors

The market is witnessing significant growth due to rising financial support from various sectors. The increased investment is primarily aimed at addressing the underlying causes of the condition, discovering new treatment options, and identifying key markers of ruptures. In September 2023, the Brain Aneurysm Foundation (BAF), granted USD 5 million in research funding to support 17 intracranial aneurysm-related research efforts.  Such grants are expected to improve the treatment options available for the patients, which is likely to the augment intracranial aneurysm market value in coming years.

 
Technological innovations such as the integration of artificial intelligence and machine learning are increasingly employed to diagnose and manage intracranial aneurysms. These developments coupled with the expansion of healthcare access and rising awareness regarding the condition are anticipated to boost the market growth.

Global Intracranial Aneurysm Market Segmentation

“Global Intracranial Aneurysm Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

By treatment type, the market includes surgical clipping, endovascular coiling, flow diverters, and other emerging interventions. Surgical clipping is an invasive method where a clip is placed to isolate the aneurysm from the parent artery, thereby preventing rupture. Endovascular coiling is a less invasive method that involves placing a coil into the aneurysm, inducing a clot.

In terms of end-users, the intracranial aneurysm market share includes hospitals, ambulatory surgical centers, and other healthcare facilities where patients receive treatment for intracranial aneurysms.

Geographically, the market report offers insights into major regional markets including North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. The regional markets are experiencing significant growth which can be attributed to the evolving regulatory policies, the growing inclination of patients towards minimally invasive procedures to treat intracranial aneurysms, and the rising emphasis on patient-centered care.

Global Intracranial Aneurysm Market: Competitive Landscape

The key market players are contributing to the intracranial aneurysm market growth through strategic partnerships, innovative product launches, and robust research and development initiatives aimed at technological advancement.

Other key players in the market include Terumo Corporation, Delta Surgical, Integra LifeSciences Corporation, Mizuho Medical Co. Ltd, evonos GmbH & Co. KG, and RAUMEDIC AG.

Global Intracranial Aneurysm Market Analysis by Region

North America holds a significant share of the market due to the high prevalence rate of intracranial aneurysms in the region. Around 1 in 50 people in the United States have an unruptured brain aneurysm, with the data suggesting that a rupture happens every 18 minutes. This rising burden of the condition  drives the demand for effective diagnosis and treatment strategies.

In Europe, the market growth is driven by the rising geriatric population prone to developing intracranial aneurysms. The increased patient preference towards less invasive procedures such as endovascular coils and stents as well as the presence of advanced healthcare infrastructure is expected to further fuel the market demand in the region.

Key Highlights of the Report